Published in The Annals of Thoracic Surgery
Background. The heparin protocols used during cardiopulmonary bypass (CPB) in children undergoing surgical repair for congenital heart disease are extrapolated from adult data. Studies are needed that assess the optimal heparin dosing in these children, whose heparin clearance is increased compared with that in adults. Methods. We assessed the effe...
Diamond-like carbon (DLC) and silicon carbide (SiC) coat- ings are attractive because of low friction coefficient, high hardness, chemical inertness and smooth finish, which they provide to biomedical devices. Silicon wafers (Si and silicone rubber (Si) plates were coated using plasma- enhanced chemical vapour deposition (PE-CVD) tech- niques. This...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
Lupus anticoagulants (LAC) are associated with thromboembolic complications (TEC). LAC can be detected via their anticoagulant properties in coagulation tests and thrombin generation assays, via the peak height (PH) and lag time (LT). To assess the thrombotic risk in LAC-positive patients, we have presently expressed the LAC-activity quantitatively...
